106 related articles for article (PubMed ID: 3004721)
21. Comparison between starvation and consumption of a high protein diet: plasma insulin and glucagon and hepatic activities of gluconeogenic enzymes during the first 24 hours.
Boisjoyeux B; Chanez M; Azzout B; Peret J
Diabete Metab; 1986 Feb; 12(1):21-7. PubMed ID: 3009246
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of hormonal regulation of liver metabolism.
Exton JH; Blackmore PF; El-Refai MF; Dehaye JP; Strickland WG; Cherrington AD; Chan TM; Assimacopoulos-Jeannet FD; Chrisman TD
Adv Cyclic Nucleotide Res; 1981; 14():491-505. PubMed ID: 6116389
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
24. Liver glycogen metabolism during short-term insulin-induced hypoglycemia in fed rats.
Obici S; Lopes-Bertolini G; Curi R; Bazotte RB
Cell Biochem Funct; 2008 Oct; 26(7):755-9. PubMed ID: 18800354
[TBL] [Abstract][Full Text] [Related]
25. Impaired plasma cyclic AMP response to exogenous glucagon in acute liver injury.
Miyakoshi H; Noda Y; Uchida S; Tanaka N; Noto Y; Kato Y; Kawai K; Hayakawa H; Kobayashi K; Hattori N
J Clin Gastroenterol; 1984 Aug; 6(4):337-42. PubMed ID: 6090530
[TBL] [Abstract][Full Text] [Related]
26. Glucagon and choleragen stimulation of glycogenolysis in primary cultures of adult rat liver parenchymal cells: lack of involvement of the glucocorticoids.
Kletzien RF; Weber CA; Butcher FR; Stumpo DJ
J Cell Physiol; 1982 Mar; 110(3):304-10. PubMed ID: 6282901
[No Abstract] [Full Text] [Related]
27. Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate action.
Christ B; Nath A; Jungermann K
Hepatology; 1997 Jul; 26(1):73-80. PubMed ID: 9214454
[TBL] [Abstract][Full Text] [Related]
28. Hepatic insensitivity to glucagon in ob/ob mice.
Yen TT; Stamm NB; Fuller RW; Root MA
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):29-40. PubMed ID: 6254120
[TBL] [Abstract][Full Text] [Related]
29. Effects of glucagon administration on microcirculation and blood rheology.
Komatsu R; Tsushima N; Matsuyama T
Clin Hemorheol Microcirc; 1997; 17(4):271-7. PubMed ID: 9493893
[TBL] [Abstract][Full Text] [Related]
30. Impaired glucose, insulin, and adenosine 3',5'-monophosphate responses to glucagon in growth hormone deficient children.
August GP; Hung W
J Clin Endocrinol Metab; 1976 Nov; 43(5):1029-35. PubMed ID: 186473
[TBL] [Abstract][Full Text] [Related]
31. Feedback-inhibition of glucagon-stimulated glycogenolysis in hepatocyte/Kupffer cell cocultures by glucagon-elicited prostaglandin production in Kupffer cells.
Hespeling U; Jungermann K; Püschel GP
Hepatology; 1995 Nov; 22(5):1577-83. PubMed ID: 7590678
[TBL] [Abstract][Full Text] [Related]
32. Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.
Bamonti-Catena F; Peracchi M; Conte D; Cantalamessa L; Lorenzano E; Orsatti A; Salerno F
Clin Chem Lab Med; 1998 Sep; 36(9):709-14. PubMed ID: 9804395
[TBL] [Abstract][Full Text] [Related]
33. C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.
Pun KK; Ho PW; Yeung RT
J Endocrinol Invest; 1988 May; 11(5):337-43. PubMed ID: 2846676
[TBL] [Abstract][Full Text] [Related]
34. Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.
Hendy GN; Tomlinson S; O'Riordan JL
Eur J Clin Invest; 1977 Jun; 7(3):155-60. PubMed ID: 196859
[TBL] [Abstract][Full Text] [Related]
35. [The treatment of spontaneous hypoglycemia in inoperable liver cell carcinoma with glucagon].
Mühe E; Schricker KT; Raithel D
Dtsch Med Wochenschr; 1969 Sep; 94(36):1781-5. PubMed ID: 4308900
[No Abstract] [Full Text] [Related]
36. Studies of insulin and growth hormone secretion in a subject with hepatoma and gypoglycemia.
Colwell JA; Wilber JF
Diabetes; 1971 Sep; 20(9):607-14. PubMed ID: 4328691
[No Abstract] [Full Text] [Related]
37. Plasma adenosine 3':5'--cyclic monophosphate response to glucagon in uremia.
Vlachoyannis J; Schoeppe W
Klin Wochenschr; 1982 Jul; 60(13):651-7. PubMed ID: 6289001
[TBL] [Abstract][Full Text] [Related]
38. Responses of plasma adenosine 3',5'-monophosphate, blood glucose and plasma insulin to glucagon in humans.
Søvik O; Heiervang E; Aksnes L; Selvig S
Scand J Clin Lab Invest; 1981 Nov; 41(7):669-74. PubMed ID: 6280266
[TBL] [Abstract][Full Text] [Related]
39. Plasma adenosine 3':5'-cyclic monophosphate response to glucagon in thyroid disease.
Elkeles RS; Lazarus JH; Siddle K; Campbell AK
Clin Sci Mol Med; 1975 Jan; 48(1):27-31. PubMed ID: 163165
[TBL] [Abstract][Full Text] [Related]
40. Pre- and postnatal development of insulin and glucagon receptors: potential role in energy storage and utilization.
Sperling MA; Ganguli S
J Pediatr Gastroenterol Nutr; 1983; 2 Suppl 1():S46-51. PubMed ID: 6315908
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
